BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38546924)

  • 1. Guideline-concordant breast cancer care by patient race and ethnicity accounting for individual-, facility- and area-level characteristics: a SEER-Medicare study.
    Herbach EL; Curran M; Roberson ML; Carnahan RM; McDowell BD; Wang K; Lizarraga I; Nash SH; Charlton M
    Cancer Causes Control; 2024 Mar; ():. PubMed ID: 38546924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race-Ethnicity: A SEER-Medicare Study.
    Herbach EL; Nash SH; Lizarraga IM; Carnahan RM; Wang K; Ogilvie AC; Curran M; Charlton ME
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1312-1322. PubMed ID: 37436422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
    Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
    Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
    Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
    Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
    Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
    Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural/organizational characteristics of health services partly explain racial variation in timeliness of radiation therapy among elderly breast cancer patients.
    Wheeler SB; Carpenter WR; Peppercorn J; Schenck AP; Weinberger M; Biddle AK
    Breast Cancer Res Treat; 2012 May; 133(1):333-45. PubMed ID: 22270934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-clinician interactions and disparities in breast cancer care: the equality in breast cancer care study.
    Gonzales FA; Sangaramoorthy M; Dwyer LA; Shariff-Marco S; Allen AM; Kurian AW; Yang J; Langer MM; Allen L; Reeve BB; Taplin SH; Gomez SL
    J Cancer Surviv; 2019 Dec; 13(6):968-980. PubMed ID: 31646462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study.
    Montes de Oca MK; Wilson LE; Previs RA; Gupta A; Joshi A; Huang B; Pisu M; Liang M; Ward KC; Schymura MJ; Berchuck A; Akinyemiju TF
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1255-1266.e11. PubMed ID: 36351338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
    Sung H; Wiese D; Jatoi I; Jemal A
    JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial disparities in guideline-concordant cancer care and mortality in the United States.
    Fang P; He W; Gomez D; Hoffman KE; Smith BD; Giordano SH; Jagsi R; Smith GL
    Adv Radiat Oncol; 2018; 3(3):221-229. PubMed ID: 30202793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.
    Collin LJ; Yan M; Jiang R; Gogineni K; Subhedar P; Ward KC; Switchenko JM; Lipscomb J; Miller-Kleinhenz J; Torres MA; Lin J; McCullough LE
    J Natl Compr Canc Netw; 2021 Aug; 19(11):1242-1251. PubMed ID: 34399407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nationwide analysis of disparities in guideline-concordant care in American Indians and Alaska Natives with stage I non-small cell lung cancer.
    Schoephoerster J; Praska C; White M; Salami A; Marmor S; Andrade R; Bhargava A; Diaz-Gutierrez I; Hui J; Tuttle T; Owen M; Rao M
    J Thorac Dis; 2023 Nov; 15(11):5891-5900. PubMed ID: 38090326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Differences in Receipt of Nonpharmacologic Care for Chronic Low Back Pain Among Medicare Beneficiaries With OUD.
    Bhondoekhan F; Marshall BDL; Shireman TI; Trivedi AN; Merlin JS; Moyo P
    JAMA Netw Open; 2023 Sep; 6(9):e2333251. PubMed ID: 37698860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does structural racism impact receipt of NCCN guideline-concordant breast cancer treatment?
    Lubarsky M; Hernandez AE; Collie BL; Westrick AC; Thompson C; Kesmodel SB; Goel N
    Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38809304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
    Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
    JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
    Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
    Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Residential Segregation and Racial and Ethnic Disparities in Severe Maternal Morbidity Before and During the COVID-19 Pandemic.
    Hung P; Liu J; Norregaard C; Shih Y; Liang C; Zhang J; Olatosi B; Campbell BA; Li X
    JAMA Netw Open; 2022 Oct; 5(10):e2237711. PubMed ID: 36264572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.